A043090 Stock Overview
Manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
The Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩273.00 |
| 52 Week High | ₩2,427.00 |
| 52 Week Low | ₩702.00 |
| Beta | 0.18 |
| 11 Month Change | -79.87% |
| 3 Month Change | -69.05% |
| 1 Year Change | -83.75% |
| 33 Year Change | -95.04% |
| 5 Year Change | -97.10% |
| Change since IPO | -98.80% |
Recent News & Updates
Investors Give The Technology Co.,Ltd. (KOSDAQ:043090) Shares A 36% Hiding
Oct 30
Is TechnologyLtd (KOSDAQ:043090) A Risky Investment?
Oct 21Slammed 27% The Technology Co.,Ltd. (KOSDAQ:043090) Screens Well Here But There Might Be A Catch
Jul 24Is TechnologyLtd (KOSDAQ:043090) Using Too Much Debt?
Jul 22Recent updates
Investors Give The Technology Co.,Ltd. (KOSDAQ:043090) Shares A 36% Hiding
Oct 30Is TechnologyLtd (KOSDAQ:043090) A Risky Investment?
Oct 21Slammed 27% The Technology Co.,Ltd. (KOSDAQ:043090) Screens Well Here But There Might Be A Catch
Jul 24Is TechnologyLtd (KOSDAQ:043090) Using Too Much Debt?
Jul 22Potential Upside For The Technology Co.,Ltd. (KOSDAQ:043090) Not Without Risk
May 22Would Exergy21 (KOSDAQ:043090) Be Better Off With Less Debt?
Feb 28Shareholder Returns
| A043090 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -71.7% | -7.6% | -0.7% |
| 1Y | -83.8% | 32.0% | -4.1% |
Return vs Industry: A043090 underperformed the KR Life Sciences industry which returned 32% over the past year.
Return vs Market: A043090 underperformed the KR Market which returned -4.1% over the past year.
Price Volatility
| A043090 volatility | |
|---|---|
| A043090 Average Weekly Movement | 26.2% |
| Life Sciences Industry Average Movement | 8.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A043090's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A043090's weekly volatility has increased from 15% to 26% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 21 | Young-Jin Kwon | www.pharmswell.com |
The Technology Co.,Ltd. manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea. It primarily provides active pharmaceutical ingredients.
The Technology Co.,Ltd. Fundamentals Summary
| A043090 fundamental statistics | |
|---|---|
| Market cap | ₩7.39b |
| Earnings (TTM) | -₩17.18b |
| Revenue (TTM) | ₩15.75b |
0.4x
P/S Ratio-0.4x
P/E RatioIs A043090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A043090 income statement (TTM) | |
|---|---|
| Revenue | ₩15.75b |
| Cost of Revenue | ₩14.15b |
| Gross Profit | ₩1.60b |
| Other Expenses | ₩18.78b |
| Earnings | -₩17.18b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -692.48 |
| Gross Margin | 10.17% |
| Net Profit Margin | -109.08% |
| Debt/Equity Ratio | 22.7% |
How did A043090 perform over the long term?
See historical performance and comparison